Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Cognitive impairment and cortical degeneration in neuromyelitis optica.
A signal-to-noise-ratio-based analysis of multifocal visual-evoked potentials in multiple sclerosis risk assessment.
Distinctive structural and functional MRI footprint for cognitive dysfunction in pediatric MS?
Subcutaneous interferon β-1a in pediatric patients with multiple sclerosis: Regional differences in clinical features, disease management, and treatment outcomes in an international retrospective study.
Molecular Mechanisms Underlying the Effects of Statins in the Central Nervous System.
Immune surveillance in multiple sclerosis patients treated with natalizumab.
Revisiting brain atrophy and its relationship to disability in multiple sclerosis.
A Study of the Safety and Efficacy of ONO-4641 in Patients With Relapsing-Remitting Multiple Sclerosis (DreaMS)
Seeing optic neuritis through myopic eyes.
Epstein-Barr virus Peptide Presented by HLA-E is Predominantly Recognized by CD8(bright) Cells in multiple Sclerosis Patients.
Iron is a sensitive biomarker for inflammation in multiple sclerosis lesions.
1,25-Dihydroxyvitamin D3 Facilitates M2 Polarization and Upregulates TLR10 Expression on Human Microglial Cells.
Circulating mitochondrial DAMPs cause inflammatory responses to injury.
The 2D:4D ratio, a proxy for prenatal androgen levels, differs in men with and without MS.
Contribution of imaging to the diagnosis of optic neuropathies.
Defining high, medium and low impact prognostic factors for developing multiple sclerosis.
Autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: the Swedish experience.
Unraveling Natalizumab Effects on Deregulated miR-17 Expression in CD4(+) T Cells of Patients with Relapsing-Remitting Multiple Sclerosis.
▼Dimethyl fumarate for relapsing-remitting multiple sclerosis.
Microparticles bearing encephalitogenic peptides induce T-cell tolerance and ameliorate experimental autoimmune encephalomyelitis.
Janus-like opposing roles of CD47 in autoimmune brain inflammation in humans and mice.
The Arabic version of the Mayo-Portland Adaptability Inventory 4: a validation study.
Therapeutic protein-drug interaction assessment for daclizumab high-yield process in patients with multiple sclerosis using a cocktail approach.
Rituximab reduces attacks in Chinese patients with neuromyelitis optica spectrum disorders.
Studies of EN-1639A (naltrexone): a new narcotic antagonist.

Pages